Sign in

CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853899721
Phone
305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
  1. 10-Q Report Quarterly Report
  2. 25-NSE Other Notification of Removal from Listing
  3. 8-K Event Other events
  4. 4 Insider Changes in Ownership
  5. 424B3 Offering Prospectus
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13D/A Stake Beneficial Ownership Report
  14. 10-Q Report Quarterly Report
  15. 8-K Event Regulation FD disclosure
  16. 4 Insider Changes in Ownership
  17. 8-K Event Shareholder vote results
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 1 of 22 · 433 filings